Tecan Group AG (SWX:TECN)

Market Cap	2.06B
Revenue (ttm)	934.28M
Net Income (ttm)	67.66M
Shares Out	12.73M
EPS (ttm)	5.29
PE Ratio	30.59
Forward PE	21.56
Dividend	3.00 (1.85%)
Ex-Dividend Date	Apr 14, 2025

Volume	26,239
Average Volume	41,318
Open	162.10
Previous Close	161.80
Day's Range	160.50 - 166.10
52-Week Range	131.50 - 335.60
Beta	0.96
RSI	46.35
Earnings Date	Jun 12, 2025

About Tecan Group AG

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service; Synergence, a customized O...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1980
• Employees: 3,341
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: TECN

Financial Performance

In 2024, Tecan Group AG's revenue was 934.28 million, a decrease of -13.04% compared to the previous year's 1.07 billion. Earnings were 67.66 million, a decrease of -48.77%.